UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000041541
Receipt number R000046664
Scientific Title The effects of a subjective sleep improvement program on convalescent stroke patients with insomnia during hospitalization: a randomized controlled trial
Date of disclosure of the study information 2022/09/30
Last modified on 2024/04/10 11:16:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of a subjective sleep improvement program on convalescent stroke patients with insomnia during hospitalization: a randomized controlled trial

Acronym

The effects of a subjective sleep improvement program on convalescent stroke patients with insomnia during hospitalization: a randomized controlled trial

Scientific Title

The effects of a subjective sleep improvement program on convalescent stroke patients with insomnia during hospitalization: a randomized controlled trial

Scientific Title:Acronym

The effects of a subjective sleep improvement program on convalescent stroke patients with insomnia during hospitalization: a randomized controlled trial

Region

Japan


Condition

Condition

stroke

Classification by specialty

Neurology Neurosurgery Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of the subjective sleep feeling improvement program for convalescent stroke patients with insomnia who are admitted to convalescent rehabilitation hospital.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The MA version of the OSA Sleep Questionnaire calculates the average pre- and post-program 7-day scores for the five subscales, and the amount of pre- and post-program change for each subscale

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation


Institution consideration


Blocking

YES

Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Two weeks subjective sleep improvement program
sleep hygiene education and relaxation

Interventions/Control_2

Receive normal care as usual

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

The diagnosis is cerebral infarction or cerebral hemorrhage
One month has passed since the stroke

Key exclusion criteria

Those who have serious complications or physical symptoms that cannot implement the program contents
Sleep disorders other than insomnia
Those who have no sleep above the cutoff value using the Athens Insomnia Scale
Those who take regular sleeping pills
Person with dementia
Those with a diagnosis of depression or mental illness
Persons with physical disorders accompanied by sleep disorders
Stroke patients undergoing medical treatment in a private room

Target sample size

82


Research contact person

Name of lead principal investigator

1st name yoshiaki
Middle name
Last name Y-y-4419

Organization

Toyohashi Sozo University

Division name

Department of Nursing, Faculty of Health Sciences

Zip code

4408511

Address

20-1 Matsushita Ushikawacho, Toyohashi-shi, Aichi-ken

TEL

0532542111

Email

y-yamamoto@sozo.ac.jp


Public contact

Name of contact person

1st name yoshiaki
Middle name
Last name Y-y-4419

Organization

Toyohashi Sozo University

Division name

Department of Nursing, Faculty of Health Sciences

Zip code

4408511

Address

20-1 Matsushita Ushikawacho, Toyohashi-shi, Aichi-ken

TEL

0532542111

Homepage URL


Email

y-yamamoto@sozo.ac.jp


Sponsor or person

Institute

Toyohashi Sozo University

Institute

Department

Personal name



Funding Source

Organization

Absent

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toyohashi Sozo University

Address

20-1 Matsushita Ushikawacho, Toyohashi-shi, Aichi-ken

Tel

0532542111

Email

y-yamamoto@sozo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 09 Month 30 Day


Related information

URL releasing protocol

2023/3/31

Publication of results

Published


Result

URL related to results and publications

2023/3/31

Number of participants that the trial has enrolled

82

Results

Following the intervention, the OSA-MA sleep inventory score was significantly higher in the intervention group than in the control group for factor 1, sleepiness on rising (p = .010), factor 4, refreshing (p = .004) and factor 5, sleep length (p = .001).

Results date posted

2024 Year 04 Month 08 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The age of the participants was 67.4 years, and 35 (42.7%) were female. The time from stroke onset to enrolment was 39.5 days, 56 patients had cerebral infarction, and 26 had cerebral hemorrhage. The FIM was 78.9. There were 37 (45.1%) participants whose sleep status before stroke onset included insomnia symptoms, and the Athens Insomnia Scale score was 9.2. A comparison of basic attributes and the OSA-MA sleep inventory between the intervention and control groups prior to implementing the program showed no significant differences in any items.

Participant flow

From the study site, 137 patients were referred, of which 108 did not meet any exclusion criteria and consented to participate in the study. These patients were screened for insomnia, and 82 were enrolled. These 82 participants were randomized to an intervention group and a control group, with 41 in each group. Of these, 37 intervention group participants and 38 control group participants completed the program, and 4 intervention group participants and 3 control group participants dropped out (drop-out rate 8.5%).

Adverse events

NONE

Outcome measures

For the OSA-MA sleep inventory, the mean scores of the five subscales for the seven days before and after the program were calculated, and the amount of change in each subscale after the program was analyzed using a t-test, with a significance level of 5%.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 08 Month 13 Day

Date of IRB

2020 Year 08 Month 17 Day

Anticipated trial start date

2020 Year 09 Month 01 Day

Last follow-up date

2022 Year 08 Month 31 Day

Date of closure to data entry

2022 Year 09 Month 15 Day

Date trial data considered complete

2022 Year 10 Month 01 Day

Date analysis concluded

2022 Year 11 Month 01 Day


Other

Other related information



Management information

Registered date

2020 Year 08 Month 25 Day

Last modified on

2024 Year 04 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000046664


Research Plan
Registered date File name
2024/04/08 Title Page.pdf

Research case data specifications
Registered date File name

Research case data
Registered date File name
2024/04/08 Main Document.pdf